Bildkälla: Stockfoto

InDex Pharmaceuticals Q3’21: Almost There - Redeye

Redeye leaves a comment on InDex Pharmaceuticals following the announcement of its Q3 report. FPI in CONCLUDE is expected to be communicated anytime soon, and there is still a large gap to our fair value of InDex shares.

Redeye leaves a comment on InDex Pharmaceuticals following the announcement of its Q3 report. FPI in CONCLUDE is expected to be communicated anytime soon, and there is still a large gap to our fair value of InDex shares.
Börsvärldens nyhetsbrev
ANNONSER